Jixing Liu
Southern Medical University
9 Papers
Jixing Liu is an academic researcher from Southern Medical University. The author has contributed to research in topics: Medicine & Cancer research. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients
Dongni Chen,Jixing Liu,Longjun Zang,T. Xiao,Xianlin Zhang,Zheng Li,Hongwei Zhu,Wenzhe Gao,Xiao Yu +8 more
TL;DR: Wang et al. as discussed by the authors proposed a novel CSCs-related cluster of hepatocellular carcinoma (HCC) to predict patients' response to immunotherapy, and four machine learning algorithms (LASSO, RF, SVM-RFE and XGboost) were applied to distinguish different stemness subtypes.
Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy.
Xiao Li,Ting Zhang,Jian Geng,Zhuguo Wu,Liting Xu,Jixing Liu,Jianwei Tian,Zhanmei Zhou,Jing Nie,Xiaoyan Bai +9 more
TL;DR: A major role of AOPPs is revealed in triggering lipotoxicity and fibrosis via CD36-dependent Wnt/β-catenin activation, providing new evidences for understanding the role of lipid accumulation in DN.
44
Hyperhomocysteinemia Accelerates Acute Kidney Injury to Chronic Kidney Disease Progression by Downregulating Heme Oxygenase-1 Expression.
Shuang Li,Bingbing Qiu,Hong Lu,Yunshi Lai,Jixing Liu,Jiajun Luo,Fengxin Zhu,Zheng Hu,Miaomiao Zhou,Jianwei Tian,Zhanmei Zhou,Shouyi Yu,Fan Yi,Jing Nie +13 more
TL;DR: Investigation of whether hyperhomocysteinemia (Hhcy) accelerates the development of renal fibrosis after AKI indicated that Hhcy might be a novel risk factor that promotes AKI to CKD progression, and lowering Hcy level or HO-1 inductionmight be a potential therapeutic strategy to improve the outcome of AKI.
35
Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria.
Yangyang Zuo,Cong Wang,Xiaoli Sun,Chengxiao Hu,Jixing Liu,Xue Hong,Weiwei Shen,Jing Nie,Fan Fan Hou,Lili Zhou,Youhua Liu,Youhua Liu +11 more
TL;DR: In this paper, gene expression profiling in the glomeruli by RNA sequencing was used to discover matrix metalloproteinase-10 (MMP-10), a secreted zinc-dependent endopeptidase, as one of the most upregulated genes after glomerular injury.
19
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French Nilo post‐STIM study
Stéphanie Dulucq,Françoise Rigal-Huguet,Franck E. Nicolini,Pascale Cony-Makhoul,Martine Escoffre-Barbe,Martine Gardembas,Laurence Legros,Philippe Rousselot,Jixing Liu,Delphine Rea,Veronique De Mas,Sandrine Hayette,Sophie Raynaud,Fanny Robbesyn,Emilie Klein,Stephane Morisset,Francois-Xavier Mahon,Gabriel Etienne +17 more
TL;DR: In this paper , the efficacy and safety of nilotinib (300mg twice daily) in chronic myeloid leukaemia (CML) patients who experienced MRec, after imatinib discontinuation, was evaluated.
10